Join the Hypoglycemia group to help and get support from people like you.
Hypoglycemia News
Related terms: Low Blood Sugar
Long-Term Sulfonylurea Use Tied to Impaired Awareness of Hypoglycemia
TUESDAY, July 23, 2024 – The prevalence of impaired awareness of hypoglycemia (IAH) is high among patients using sulfonylureas long term, according to a study published in the July/August issue of...
FDA Warns of Smartwatches That Claim to Measure Glucose Levels
THURSDAY, Feb. 22, 2024 – The U.S. Food and Drug Administration has issued an advisory regarding smartwatches and smart rings that claim to track blood glucose levels. "Sellers of these smartwatches...
Don't Use Smartwatches That Claim to Measure Blood Sugar, FDA Warns
THURSDAY, Feb. 22, 2024 – Some Americans living with diabetes are using smartwatches and smart rings that claim to be able to track their blood sugar. However, such claims from any device that does...
Decision Support Tool Cuts Hypoglycemia Risk in Older Adults
WEDNESDAY, Oct. 11, 2023 – In a population of at-risk older patients, the use of a clinical decision support tool and shared decision-making can reduce the risk for hypoglycemia by nearly half,...
FDA Medwatch Alert: Eli Lilly and Company Issues Voluntary Nationwide Recall of One Lot of Glucagon® Emergency Kit Due to Loss of Potency
INDIANAPOLIS, Sept. 24, 2021 -- Eli Lilly and Company (NYSE: LLY) is voluntarily recalling lot D239382D, Expiration April 2022, of Glucagon Emergency Kit for Low Blood Sugar (Glucagon for Injection, ...
Xeris Pharmaceuticals Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke Kit for the Treatment of Severe Hypoglycemia
First ready-to-use liquid glucagon available in a single-dose vial and syringe kit for rescue Gvoke HypoPen®, Gvoke® PFS, and Gvoke® Kit – three different administration options to accommodate pati...
FDA Approves Zegalogue (dasiglucagon) Injection for the Treatment of Severe Hypoglycemia in People with Diabetes
Copenhagen, DK and Boston, MA, U.S. March 22, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company aspiring to deliver innovation with novel peptide therapeutics, an...
FDA Approves Gvoke (glucagon), the First Ready-to-use Stable Liquid Glucagon for Severe Hypoglycemia
CHICAGO--(BUSINESS WIRE)--Sep. 10, 2019-- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize...
FDA Approves Baqsimi (glucagon) Nasal Powder for the Treatment of Severe Hypoglycemia
July 24, 2019 – The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be...
FDA Medwatch Alert: GlucaGen HypoKit (glucagon [rDNA origin] for injection) by Novo Nordisk Inc: Recall - Detached Needles on Syringe
ISSUE: Novo Nordisk Inc. is recalling six batches of the GlucaGen HypoKit in the U.S. due to two customer complaints from the UK and Portugal involving detached needles on the syringe with Sterile...
FDA Medwatch Alert: Proglycem (diazoxide): Drug Safety Communication - Reports of Pulmonary Hypertension in Infants and Newborns
[Posted 07/16/2015] ISSUE: FDA is warning that a serious lung condition called pulmonary hypertension, which is high pressure in the blood vessels leading to the lungs, has been reported in ...